Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	550.94	304.96	13.52	14.85	10.29
Cash & Short-Term Investments	550.94	304.96	13.52	14.85	10.29
Cash Growth	80.66%	2155.15%	-8.95%	44.36%	-95.83%
Accounts Receivable	93.32	86.37	-	-	-
Other Receivables	-	-	3.36	8.53	2.99
Total Trade Receivables	93.32	86.37	3.36	8.53	2.99
Inventory	39.17	33.73	-	-	-
Other Current Assets	44.09	129.25	2.27	3.66	1.72
Total Current Assets	727.52	554.31	19.15	27.05	15
Net Property, Plant & Equipment	12.48	2.97	57.28	46.65	38.07
Other Intangible Assets	182.16	208.43	-	-	-
Goodwill	17.91	17.91	3.49	3.49	3.49
Long-Term Investments	598.22	393.96	-	-	-
Other Long-Term Assets	96.88	123.49	18.45	18.65	13.21
Total Assets	1,635	1,301	98.36	95.83	69.77
Accounts Payable	4.97	2.13	5.69	6.03	2.27
Accrued Expenses	40.19	40.8	0.77	1.83	1.04
Short-Term Debt	-	192.03	-	-	-
Current Portion of Leases	-	-	9.48	17.01	1.51
Unearned Revenue	4.27	1.13	-	-	-
Other Current Liabilities	0.27	-	0.52	-	-
Total Current Liabilities	49.7	236.08	16.46	24.87	4.81
Long-Term Debt	257.73	256.32	82.31	23.67	-
Long-Term Leases	-	-	28.58	31.8	36.48
Other Long-Term Liabilities	154.9	117.5	3.08	3.08	3.08
Total Long-Term Liabilities	412.63	373.82	113.97	58.56	39.56
Total Liabilities	462.32	609.9	130.43	83.43	44.37
Common Stock	0.75	0.63	0.36	0.36	0.27
Additional Paid-in Capital	902.73	692.33	276.39	275.49	227.98
Retained Earnings	269.37	-1.8	-308.82	-239.77	-202.86
Total Common Shareholders' Equity	1,173	691.16	-32.07	36.08	25.4
Shareholders' Equity	1,173	691.16	-32.07	36.08	25.4
Total Liabilities & Equity	1,635	1,301	98.36	95.83	69.77
Total Debt	257.73	448.34	120.37	72.49	37.99
Net Cash (Debt)	293.21	-143.38	-106.85	-57.64	-27.7
Net Cash Per Share	3.46	-1.93	-1.23	-0.60	-0.29
Book Value	1,173	691.16	-32.07	36.08	25.4
Book Value Per Share	13.84	9.32	-0.37	0.38	0.27
Tangible Book Value	972.78	464.82	-35.56	32.59	21.91
Tangible Book Value Per Share	11.48	6.27	-0.41	0.34	0.23

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q